| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aldeyra Therapeutics, Inc. (ALDX) has 2 insiders with recent SEC Form 4 filings, including 13 buys and 0 sells. ALDX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 221.8K | $434.7K | - | |
| Other | 7.5K | $14.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 29, 2022 | Perceptive Advisors LLC51 | 10% Owner | Buy | 222,123 | $5.03 | $1,117,278.69 | +2.2% | +9.9% | +58.1% | |
| Jul 28, 2022 | Perceptive Advisors LLC51 | 10% Owner | Buy | 119,392 | $5.00 | $596,960.00 | +1.2% | +13.2% | +59.4% | |
| Jun 23, 2022 | Brady Todd C | President And CEO | Buy | 17,700 | $3.36 | $59,546.34 | +1.5% | +61.6% | +98.1% | |
| Jun 23, 2022 | Joyce Martin Joseph | Director | Buy | 4,323 | $3.48 | $15,024.59 | +22.0% | +61.6% | +98.1% | |
| May 3, 2021 | Perceptive Advisors LLC51 | 10% Owner | Buy | 1,200,000 | $12.50 | $15,000,000.00 | +13.8% | -27.8% | -76.2% | |
| Jan 19, 2021 | Perceptive Advisors LLC51 | 10% Owner | Buy | 1,368,421 | $9.50 | $12,999,999.50 | +18.7% | - | - | |
| Jan 8, 2021 | Perceptive Advisors LLC51 | 10% Owner | Buy | 1,050,000 | $8.76 | $9,202,668.00 | +3.8% | - | - | |
| Jul 9, 2020 | Perceptive Advisors LLC51 | 10% Owner | Buy | 3,200,000 | $4.25 | $13,600,000.00 | +103.7% | - | - | |
| Mar 16, 2020 | Douglas Richard | Director | Buy | 40,000 | $2.75 | $110,000.00 | +47.1% | - | - | |
| Dec 16, 2019 | Brady Todd C | President And CEO | Buy | 20,000 | $5.10 | $101,908.00 | +3.2% | - | - |